Dr. Imad M. Nakshabendi, MD

Dr. Nakshabendi practices at Ambulatory Surgery Center Tampa in Tampa, Florida.

Dr. Nakshabendi's NPI, 1689621054, was assigned on May 30, 2006. Dr. Nakshabendi graduated from University of Baghdad College of Medicine in 1978. Dr. Nakshabendi holds Florida license ME0079277.

Dr. Nakshabendi's primary practice is Ambulatory Surgery Center Tampa, at 4500 E Fletcher Ave, Tampa, FL 33613. The practice phone is (813) 977-8550.

Dr. Nakshabendi's primary practice is Ambulatory Surgery Center Tampa in Tampa, Florida. Dr. Nakshabendi is also affiliated with AdventHealth Tampa. The medical group on file is Florida Advanced Gastroenterology Center. Dmand AI also links Dr. Nakshabendi to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakshabendi practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Nakshabendi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Nakshabendi's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic anemia, chronic diabetes, chronic hypertension, chronic indigestion, chronic inflammatory bowel disease (IBD) and cirrhosis of the liver among the conditions Dr. Nakshabendi treats.

CMS data shows 2,171 Medicare services from Dr. Nakshabendi across 13 procedure codes in 2024, for 709 Medicare patients. Medicare paid $157,602 for them.

CMS counts 709 Medicare patients who saw Dr. Nakshabendi in 2024. The largest group is 65 to 74, with 346 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakshabendi's median patient age at 60, with 59% women.

In 2024, Dr. Nakshabendi wrote 1,294 Medicare Part D claims for 531 patients. 80% of them were for generic drugs. CMS names the drug for 1,184 of them, across 18 drugs with 11 or more claims each, at $359,898 in total drug cost. In 2023, CMS named 3,434 claims across 32 drugs.

Dr. Nakshabendi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nakshabendi as offering telehealth. CMS counts 111 procedures of colonoscopy by Dr. Nakshabendi, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Nakshabendi in 2016. Dr. Nakshabendi's most frequent co-author is Francis Daniel Labarbera, MD.

CMS Open Payments shows 606 general payments to Dr. Nakshabendi from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $3,537.

Dmand AI lists 1 award for Dr. Nakshabendi, most recently CMS Stage 1 EHR in 2013.

Dr. Nakshabendi graduated from University of Baghdad College of Medicine in 1978. Dr. Nakshabendi is a member of ACG, ACP, AGA and ASGE.

Dr. Nakshabendi is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.